Results 41 to 50 of about 897,483 (151)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

open access: yesCancer Management and Research, 2019
Casadei-Gardini A, Montagnani F, Casadei C, et al. Cancer Manag Res. 2019;11:3631–3642. The authors have advised that the affiliations are not correct in the published paper (page 3631).
Casadei-Gardini A   +24 more
doaj  

Scope of services provided to childhood cancer patients by the Brazilian Pediatric Palliative Care Network

open access: yesFrontiers in Oncology
IntroductionBrazil is a developing and an Upper Middle Income, categorized by the World Bank. Therefore, it is a country that needs a special vision for children with oncological diseases who require Pediatric Palliative Care.
Esther Angélica Luiz Ferreira   +23 more
doaj   +1 more source

The action of Palbociclib on the Cell Cycle of Head and Neck Squamous Cell Carcinoma: A Systematic Review

open access: yesBrazilian Journal of Oncology
This study evaluates the action of Palbociclib in the cell cycle of HPV-negative head and neck squamous cell carcinoma. Initially approved for HER2- and HR + breast cancer.
Maria Eduarda Bertolazzi Teixeira   +2 more
doaj   +1 more source

Use of electronic medical records in oncology outcomes research

open access: yesClinicoEconomics and Outcomes Research, 2010
Gena Kanas1, Libby Morimoto1, Fionna Mowat1, Cynthia O’Malley2, Jon Fryzek3, Robert Nordyke21Exponent, Inc., Menlo Park, CA, USA; 2Amgen, Inc., Thousand Oaks, CA, USA; 3MedImmune, Gaithersburg, MD, USAAbstract: Oncology outcomes research could ...
Gena Kanas   +3 more
doaj  

Tislelizumab—Current Status and Future Directions: A Review Article

open access: yesIndian Journal of Medical and Paediatric Oncology
Tislelizumab is a humanized IgG4 monoclonal antibody targeting programmed death-1 (PD-1), uniquely engineered to minimize Fcγ-receptor (FcγR) binding on macrophages, thereby reducing macrophage-mediated clearance of PD-1-expressing effector T cells. This
Praloy Basu
doaj   +1 more source

Anaplastic Thyroid Carcinoma versus Metastatic SCC: A Diagnostic Dilemma in a Rare Presentation of Post-Radiation Thyroid Swelling

open access: yesIndian Journal of Medical and Paediatric Oncology
A 71-year-old male with type 2 diabetes and hypertension was diagnosed with carcinoma of the pyriform fossa in 2019. The biopsy was reported as a moderately differentiated squamous cell carcinoma, and positron emission tomography-computed tomography (PET-
Vrushab Rao, Bhooshan Zade
doaj   +1 more source

PRECISION ONCOLOGY WITH ELECTRONIC MEDICAL RECORDS

open access: yesEuropean Medical Journal Innovations, 2018
Electronic medical record (EMR)-based precision oncology is a vision that is so far limited to a few pilot and basket studies, with the goal being the design of a proper treatment for cancer patients in real time, based on the panomics knowledge of the ...
Losiana Nayak, Rajat K. De
doaj  

The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study

open access: yesCancer Medicine
Objective Current studies have indicated that diabetes mellitus (DM) is highly prevalent in patients with cancer, but there is little research on consequences on the well‐being of patients during cancer treatment. This analysis evaluates the relationship
Dominik J. Ose   +12 more
doaj   +1 more source

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023. [PDF]

open access: yesESMO Open, 2023
Cufer T   +2 more
europepmc   +2 more sources

Supplementum 293: Abstracts of the Swiss Oncology & Hematology Congress (SOHC) (Basel, Switzerland, November 19-21, 2025)

open access: yesSwiss Medical Weekly
Swiss Society of Medical Oncology   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy